跳至主要内容
临床试验/IRCT20101130005280N31
IRCT20101130005280N31招募中2 期

Study of the effect of Atomoxetine in comparison with placebo on cognitive symptoms in patients with schizophrenia

Mashhad University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • 2nd Generation Antipsychotic Drug use
  • Lack of dementia
  • Not taking other medicines (except anticholinergics and benzodiazepines)
  • No pregnancy or breastfeeding
  • There is no recent history of drugs (except nicotine)
  • schizophrenic patients during partial recovery

排除标准

  • Drug side effects including: abdominal discomfort, loss of appetite resulting in weight loss, dizziness, irritability and mood swings
  • Occurrence of drug interactions with patient medications

研究者

相似试验